Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remodeling Evaluation and Stabilization of Carotid Vulnerable Plaques by PCSK9 Inhibitors Using HR-MRI for Early Prediction

NCT07819643 is registered in ClinicalTrials.gov with Keqiang Zhao as lead sponsor.

NCT NCT07819643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07819643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remodeling Evaluation and Stabilization of Carotid Vulnerable Plaques by PCSK9 Inhibitors Using HR-MRI for Early Prediction
Lead sponsor
Keqiang Zhao
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
December 1, 2029
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis cerebral, carotid plaque, carotid stenosis, vulnerable plaque